Blair William & Co. IL Reduces Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Blair William & Co. IL lowered its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 212,015 shares of the pharmacy operator’s stock after selling 8,688 shares during the quarter. Blair William & Co. IL’s holdings in Walgreens Boots Alliance were worth $2,564,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Norges Bank bought a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at $29,816,000. Coldstream Capital Management Inc. bought a new stake in Walgreens Boots Alliance during the fourth quarter worth about $326,000. D.A. Davidson & CO. boosted its stake in Walgreens Boots Alliance by 6.3% during the fourth quarter. D.A. Davidson & CO. now owns 57,780 shares of the pharmacy operator’s stock worth $1,509,000 after acquiring an additional 3,449 shares in the last quarter. Corient Private Wealth LLC grew its holdings in Walgreens Boots Alliance by 38.9% in the fourth quarter. Corient Private Wealth LLC now owns 280,545 shares of the pharmacy operator’s stock worth $7,325,000 after purchasing an additional 78,523 shares during the period. Finally, Quest Partners LLC purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $30,000. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $8.71 on Monday. The firm has a market capitalization of $7.52 billion, a P/E ratio of -1.29, a PEG ratio of 1.02 and a beta of 0.70. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31. Walgreens Boots Alliance, Inc. has a one year low of $8.46 and a one year high of $27.05. The business has a fifty day moving average of $10.29 and a 200 day moving average of $14.68.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The firm had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. During the same quarter in the prior year, the firm earned $1.00 earnings per share. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.86 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st were given a $0.25 dividend. The ex-dividend date was Wednesday, August 21st. This represents a $1.00 annualized dividend and a yield of 11.48%. Walgreens Boots Alliance’s payout ratio is presently -14.84%.

Wall Street Analyst Weigh In

WBA has been the topic of several recent research reports. Barclays cut their price target on Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating on the stock in a research note on Tuesday, July 23rd. Evercore ISI lowered their price target on Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating for the company in a research report on Friday, June 28th. TD Cowen dropped their price target on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating on the stock in a research note on Thursday, September 12th. Bank of America reduced their price objective on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. Finally, UBS Group cut their price target on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a report on Wednesday, July 3rd. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and a consensus target price of $14.73.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.